$5.08
0.11[2.21%]
At close: Apr 24
$5.08
0[0.00%]
PreMarket: 8:37AM EDT
ADC Therapeutics
(NYSE:ADCT)ADC Therapeutics Stock (NYSE:ADCT), Earnings Estimates, EPS, and Revenue
ADC Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.540
Quarterly Revenue Estimate
$18.4M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$69.6M
Analyze the earnings history of ADC Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/07/2024 | AM | ADCT | Q1 | -$0.53 | -$0.54 | — | — | $18.99M | $18.40M | — | — | Get Alert |
| 03/13/2024 | AM | ADCT | Q4 | -$0.08 | -$0.50 | -$0.97 | -94.00% | $69.80M | $15.33M | $16.79M | 9.52% | Get Alert |
| 11/07/2023 | AM | ADCT | Q3 | $0.13 | -$0.63 | -$0.41 | 34.92% | $76.32M | $15.99M | $14.49M | -9.36% | Get Alert |
| 08/08/2023 | AM | ADCT | Q2 | -$0.73 | -$0.44 | -$0.37 | 15.91% | $17.29M | $34.77M | $19.28M | -44.54% | Get Alert |
| 05/09/2023 | AM | ADCT | Q1 | -$0.36 | -$0.67 | -$0.53 | 20.90% | $46.50M | $20.09M | $18.99M | -5.47% | Get Alert |
| 02/28/2023 | AM | ADCT | Q4 | -$0.39 | -$0.29 | -$0.10 | 65.52% | $17.01M | $65.49M | $69.80M | 6.58% | Get Alert |
| 11/08/2022 | AM | ADCT | Q3 | -$0.59 | -$0.35 | $0.13 | 137.14% | $13.15M | $47.01M | $76.32M | 62.35% | Get Alert |
| 08/09/2022 | AM | ADCT | Q2 | -$0.70 | -$0.91 | -$0.73 | 19.78% | $3.76M | $20.51M | $17.29M | -15.69% | Get Alert |
| 05/09/2022 | AM | ADCT | Q1 | -$0.74 | -$0.70 | -$0.36 | 48.57% | $0.00 | $28.94M | $46.50M | 60.67% | Get Alert |
| 03/03/2022 | AM | ADCT | Q4 | -$0.82 | -$0.86 | -$0.39 | 54.65% | $0.00 | $16.46M | $17.01M | 3.34% | Get Alert |
| 11/02/2021 | AM | ADCT | Q3 | -$0.58 | -$0.92 | -$0.59 | 35.87% | $0.00 | $7.39M | $13.15M | 77.90% | Get Alert |
| 08/03/2021 | AM | ADCT | Q2 | -$0.51 | -$0.82 | -$0.70 | 14.63% | $0.00 | $2.37M | $3.76M | 58.65% | Get Alert |
| 05/06/2021 | AM | ADCT | Q1 | — | -$0.90 | -$0.74 | 17.78% | — | $90.00K | $0.00 | -100.00% | Get Alert |
| 03/18/2021 | AM | ADCT | Q4 | — | -$0.38 | -$0.82 | -115.79% | — | $860.00K | $0.00 | -100.00% | Get Alert |
| 11/12/2020 | AM | ADCT | Q3 | — | -$0.81 | -$0.58 | 28.40% | — | $40.00K | $0.00 | -100.00% | Get Alert |
| 08/18/2020 | AM | ADCT | Q2 | — | -$0.67 | -$0.51 | 23.88% | — | $290.00K | $0.00 | -100.00% | Get Alert |
FAQ
When is ADC Therapeutics (NYSE:ADCT) reporting earnings?
ADC Therapeutics (ADCT) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on March 13, 2024 for Q4.
What were the latest earnings per share (EPS) for ADC Therapeutics (NYSE:ADCT)?
The Actual EPS was $-0.97, which missed the estimate of $-0.50.
What were ADC Therapeutics’s (NYSE:ADCT) revenues?
The Actual Revenue was $16.8M, which beat the estimate of $15.3M.
Browse earnings estimates, EPS, and revenue on all stocks.